Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Nicholas Hilker"'
Autor:
David Z. Rose, John N. Meriwether, Michael G. Fradley, Swetha Renati, Ryan C. Martin, Thomas Kasprowicz, Aarti Patel, Maxim Mokin, Ryan Murtagh, Kevin Kip, Andrea C. Bozeman, Tara McTigue, Nicholas Hilker, Bonnie Kirby, Natasha Wick, Nhi Tran, W. Scott Burgin, Arthur J. Labovitz
Publikováno v:
Frontiers in Neurology, Vol 10 (2019)
Background: Optimal timing to initiate anticoagulation after acute ischemic stroke (AIS) from atrial fibrillation (AF) is currently unknown. Compared to other stroke etiologies, AF typically provokes larger infarct volumes and greater concern of hemo
Externí odkaz:
https://doaj.org/article/e865179544e84a739b7fdbf9639fcc4e
Autor:
Swetha Renati, Nicholas Hilker, Marla Hairston, Weiliang Cen, Henian Chen, Andrea Bozeman, Kanita Beba Abadal, David Rose, William S Burgin
Publikováno v:
Stroke. 54
Introduction: After an ischemic stroke or transient ischemic attack (TIA), patients may have post-event anxiety and re-experience transient neurological symptoms. However, some stroke patients develop persistent and disabling symptoms of post-traumat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::37f27baea5df1efcd9afdffcccdbed5e
https://doi.org/10.1161/str.54.suppl_1.wp61
https://doi.org/10.1161/str.54.suppl_1.wp61
Autor:
Scott Drake, David Z. Rose, Karen Packer Wilson, Nicole Slye, W. S Burgin, Nicholas Hilker, Swetha Renati, Henian Chen
Publikováno v:
Stroke. 51
Background: Vital signs and neurologic assessments are currently performed using the schedule utilized during the clinical trials which led to the approval of alteplase for acute stroke. These assessments can be disruptive to patients and represent a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::abcc8cfdeb14e087cfb2b1c8cae0e8df
https://doi.org/10.1161/str.51.suppl_1.tp401
https://doi.org/10.1161/str.51.suppl_1.tp401
Autor:
Nhi Tran, Michael G. Fradley, Kevin E. Kip, Swetha Renati, Bonnie Kirby, Ryan C. Martin, Andrea C. Bozeman, W. Scott Burgin, Thomas Kasprowicz, David Z. Rose, Ryan Murtagh, Arthur J. Labovitz, John N. Meriwether, Maxim Mokin, Nicholas Hilker, Natasha Wick, Tara McTigue, Aarti Patel
Publikováno v:
Frontiers in Neurology
Frontiers in Neurology, Vol 10 (2019)
Frontiers in Neurology, Vol 10 (2019)
Background: Optimal timing to initiate anticoagulation after acute ischemic stroke (AIS) from atrial fibrillation (AF) is currently unknown. Compared to other stroke etiologies, AF typically provokes larger infarct volumes and greater concern of hemo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1a89cbe352643aea1baf9a490f4664d
https://doi.org/10.3389/fneur.2019.00975
https://doi.org/10.3389/fneur.2019.00975
Autor:
Swetha Renati, Nicole Slye, W. S Burgin, Abdelrahman Beltagy, Nicholas Hilker, David Z. Rose, Henian Chen, Jasmina Ehab
Publikováno v:
Stroke. 50
Background: Most stroke patients have their stroke in the community setting, however a significant minority occur while hospitalized for another condition. Prior studies have noted worse outcomes for in-hospital strokes(IHS) compared to community-ons
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::380941c2fd34a68fb7f0c89c00d16a57
https://doi.org/10.1161/str.50.suppl_1.tmp86
https://doi.org/10.1161/str.50.suppl_1.tmp86
Publikováno v:
Stroke. 50
Background: Despite the efficacy of Direct Oral Anticoagulants (DOACs) in Nonvalvular Atrial Fibrillation (NVAF), some patients may still develop an ischemic stroke while taking this medication. This can be from a primary efficacy problem, called DOA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::23af0241144d20e1420e30262f8fd6d4
https://doi.org/10.1161/str.50.suppl_1.wp269
https://doi.org/10.1161/str.50.suppl_1.wp269